Michelson Diagnostics
Smith & Nephew gets in on Michelson Diagnostics Series B round
Michelson Diagnostics lands $3M in Series A2 financing
Michelson Diagnostics brought in $3.2 million in its Series A2 financing round, planning on using the funds to support its VivoSight device.
England-based Michelson develops and commercializes non-invasive diagnostic and monitoring equipment. The company’s flagship product is the VivoSight OCT scanner, which produces high definition images of the layers of the skin and subsurface features, allowing physicians and dermatologists to make accurate treatment decisions concerning what they see.